Takeda Initiative with the Global Fund

Partnership Objective

Help strengthen healthcare systems mainly through training of healthcare workers in Africa.

A healthcare worker in Tanzania explains how to use an insecticide-treated mosquito net for malaria prevention. A healthcare worker in Tanzania explains how to use an insecticide-treated mosquito net for malaria prevention. Copyright Takeda

What are the health needs and challenges?

Controlling the spread of the three major infectious diseases malaria, TB and HIV/AIDS is part of the United Nations Agenda for Sustainable Development. Lack of trained healthcare workers is particularly severe in Africa and poses a major obstacle to providing the healthcare services required to combat infectious diseases.

Description of partnership activities and how they address needs and challenges

The Takeda Initiative is an endowment made by Takeda Pharmaceutical, with an annual value of JPY 100,000,000 (approximately USD 1 million). It will support the Global Fund to Fight AIDS, Tuberculosis and Malaria over the period 2010-2019 in training health care workers and strengthening of healthcare systems in Africa.

During the first phase, the initiative focuses on:

Tanzania (target disease: malaria): Supporting the National Insecticide Treated Nets Implementation Plan (NATNETS) by improving the distribution of insecticide-treated nets and by training people engaged in promoting the use of nets;

Nigeria (target disease: HIV/AIDS): Scaling-up of comprehensive HIV/AIDS treatment, care and support, training staff members from not-for-profit and grassroots organizations engaged in providing community-based care for HIV/AIDS patients and orphans, and advocacy and awareness increasing activities;

Senegal and Kenya (target disease: tuberculosis): Strengthening tuberculosis control by training healthcare workers engaged in tuberculosis diagnosis and treatment.

Partnership information

Company(ies) Takeda

Partner(s) Global Fund to Fight AIDS, Tuberculosis and Malaria

Type of Partner(s) Multilaterals

Therapeutic Focus Infectious Diseases

Disease(s) HIV/AIDS, Malaria, Tuberculosis

Program Type(s) Availability of Treatment - Financial Support, Health System Infrastructure - Provision of Insecticide Nets, Health System Infrastructure - Training, Prevention Programs - Awareness & Outreach

Targeted Population(s) Children, Mothers, Patients in needs of treatment, People with low income

Region(s) Sub-Saharan Africa

Number of Countries 3

Country(ies) Nigeria, Senegal, Tanzania

Start Date 2010

More information The Global Fund

Anticipated completion date 2019

« The Global Fund is an excellent vehicle for Takeda to contribute to and support people affected by AIDS, tuberculosis and malaria while also helping to strengthen health systems in developing countries. »

Yasuchika Hasegawa, President & CEO Takeda Pharmaceutical